Παρασκευή 6 Νοεμβρίου 2015

Μουσική και Επιληψία - Μοτσαρτ



Mozart's music in children with drug-refractory epileptic encephalopathies


Highlights

Mozart's music has been tried in children with refractory encephalopathies.
Music therapy decreased seizure recurrence in about 45% of children.
All responders also had an improvement in nighttime sleep and daytime behavior.

Abstract

Mozart's sonata for two pianos in D major, K448, has been shown to decrease interictal EEG discharges and recurrence of clinical seizures in both adults and young patients. In this prospective, open-label study, we evaluated the effect of listening to a set of Mozart's compositions, according to the Tomatis method, on sleep quality and behavioral disorders, including auto-/hetero-aggression, irritability, and hyperactivity, in a group of children and adolescents with drug-resistant epilepsy.
The study group was composed of 11 outpatients (7 males and 4 females), between 1.5 years and 21 years of age (mean age: 11.9 years), all suffering from drug-resistant epileptic encephalopathy (n = 11). All of them had a severe/profound intellectual disability associated with cerebral palsy. During the study period, each patient had to listen to a set of Mozart's compositions 2 h per day for fifteen days for a total of 30 h, which could be distributed over the day depending on the habits and compliance of each patient.
The music was filtered by a device preferably delivering higher sound frequencies (> 3000 Hz) according to the Tomatis principles. The antiepileptic drug therapy remained unchanged throughout the study period. During the 15-day music therapy, 2 out of 11 patients had a reduction of 50–75% in seizure recurrence, and 3 out of 12 patients had a reduction of 75–89%. Overall, 5 (45.4%) out of 11 patients had a ≥ 50% reduction in the total number of seizures, while the percentage decrease of the total seizure number (11/11) compared with baseline was − 51.5% during the 15-day music therapy and − 20.7% in the two weeks after the end of treatment. All responders also had an improvement in nighttime sleep and daytime behavior.

Keywords

  • Mozart's music;
  • Drug-refractory epilepsy;
  • Children;
  • Behavior;
  • Seizure recurrence

1. Introduction

Among the so-called alternative nonpharmacological treatments for drug-resistant epilepsy, in addition to surgery, vagus nerve stimulation, ketogenic diet, and deep brain stimulation, there is a growing interest in music therapy.
In fact, there are a few studies reporting that the musical stimulation, particularly the “Mozart effect” of the K448 sonata for two pianos, is able to decrease both interictal EEG discharges [1], [2] and [3] and recurrence of clinical seizures [4], [5], [6], [7] and [8].
As to the interictal discharges, there is some evidence for the particular responsiveness of generalized and central spike-and-wave discharges to music therapy [3], with an effect that persists even after discontinuing music stimulation (“carryover effect” according to Lin et al. [2]).
With respect to clinical seizures, there is only a randomized controlled trial [8] in adults with epilepsy and neurological disorders, and there are a few other small studies in children and adolescents with several forms of epilepsy (particularly idiopathic), with protocols differing for duration and kind of musical stimulation (especially Mozart K448 for 2 pianos) and length of follow-up [3], [4], [8] and [9].
In this prospective, open-label trial, we evaluated the effect of listening to a set of Mozart's compositions, according to the Tomatis method [10], on seizure recurrence, sleep quality, and behavioral disorders, including auto-/hetero-aggression, irritability, and hyperactivity, in a group of children and adolescents with drug-resistant epileptic encephalopathies.

2. Materials and methods

The patients were recruited from the center for children and adolescent epilepsy care of the Medical School of the University of Salerno.
They were selected according to the following criteria: (i) 12 months of age and over; (ii) with seizures refractory to antiepileptic drugs; (iii) with drug-resistant epilepsy and with at least four seizures a week during the 6 months before music therapy was administered; (iv) without systemic or progressive neurologic diseases (including deafness); and (v) with informed consent by parents and/or caregivers to participate in the study. Exclusion criterion was poor compliance with following the study protocol.
The protocol was approved by the Ethics Committee, and the study was not sponsored by any commercial organization.
Nonepileptic seizures were excluded by means of video-EEGs and/or long-term monitoring EEGs. Brain computed tomography/magnetic resonance imaging scans were performed in all cases. Seizure frequency, type, and duration were recorded by parents and caregivers, both at home and at school, in an epilepsy diary. Seizures were classified according to the International League Against Epilepsy (ILAE) classification of epileptic seizures [11]. The effectiveness of music therapy was rated as follows: seizure-free (100% remission); very good (50–98% decrease in seizure frequency); minimal (seizure frequency less than 50% with minimal change in seizure severity); and unmodified or worsened (seizure frequency and severity similar to [unmodified] or worse than [worsened] baseline).
Before starting the treatment (TIME 0), each patient was administered a questionnaire, designed to evaluate seizure frequency and type, quality of nocturnal sleep, and daytime behavior (irritability, fits of rage, crying spells, self-/hetero-aggression) throughout the 6 months prior to treatment onset. Laboratory evaluation including antiepileptic drug blood level, a full blood count, serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), urea, creatinine, and urinalysis, together with a sleep–wake video-EEG recording, was performed in each patient in the previous week.
On the same day, a wake video-EEG recording before, during, and after listening to the music of the same duration (20 min, respectively) was performed in each patient.
Soon after, each child was delivered with a device, and his/her parents/caregivers had an exhaustive training for home treatment.
Parents were also given an epilepsy diary in which they had to record seizure number, type, and duration both at home and at school as well as changes in the quality of nocturnal sleep and daytime behavior.
The set of music to be administered included Mozart's compositions (symphony no. 41, k551; piano concerto no. 22, k482; violin concerto no. 1, k207; violin concerto no. 4 in D major, K218, allegro aperto; symphony no. 46 in C major, kv96, allegro; flute concerto in D major K314, allegro aperto).
Mozart's compositions were modified by a device, the so-called “electronic ear”, [10]. The latter, through a system of filters, amplifiers, and sophisticated mechanisms of electronic gate, modifies the amplitude of sound frequencies preferably delivering higher sound frequencies (> 3000 Hz) which, according to Tomatis, “recharge” the cerebral cortex. The electronic ear works on the middle ear through the contraction of the muscles of the hammer and the bracket.
The sound is transmitted through both air conduction and bone conduction. Through the air, the sound signal reaches the eardrum, whose active vibration stimulates the cochlea in the inner ear. Through bone conduction, the sound message is transmitted directly on the skull from a vibrator placed on the top of the cap. The sound, in this way, directly reaches the inner ear, bypassing the eardrum.
The music had to be listened to 2 h per day for fifteen days for a total of 30 h and listening time could be distributed over the day depending on the habits and compliance of each patient. At study entry, parents were given a password to access a dedicated website and listen to Mozart's compositions. In this way, full compliance with the study protocol could be monitored. If daily music listening was irregular or insufficient, a given patient would be excluded from the study.
After 15 days (TIME 1), each patient underwent a second wake video-EEG recording lasting 20 min. The music device and the filled-in diary regarding the first 15 days of treatment were retrieved, and a blood sample for antiepileptic drug level evaluation was taken. Parents were then given a new diary to record seizure recurrence and type together with nocturnal sleep quality and behavioral changes during the next month in the absence of music stimulation.
After 1 month (TIME 2), a wake video-EEG recording was then performed on each patient. Throughout the study, no changes to the antiepileptic treatment or addition of other drugs, except rescue drugs, were allowed.
Statistical analysis was performed by means of SPSS (SPSS Inc., USA, 2006). Data are expressed as mean ± SD. The paired t-test was used to compare the percentage reduction in seizure frequency throughout the music therapy with the premusic seizure frequency set at 100%. Analysis of variance two-way analysis of variance was carried out to compare percentage seizure frequency reduction after listening to Mozart's set of compositions with respect to sex, etiology, IQ, and seizure type. A p-value less than 0.05 was set as significant.

3. Results

The study group was composed of 11 outpatients (7 males and 4 females), between 1.5 years and 21 years of age (mean age: 11.9 years), all suffering from drug-resistant epileptic encephalopathy (n = 11).
All patients (11/11) had a severe/profound intellectual disability associated with cerebral palsy (spastic tetraparesis with or without dystonia, n = 9; double hemiparesis, n = 1; right hemiparesis, n = 1).
The clinical EEG and neuroradiological features of each patient are summarized in Table 1.
Table 1. Clinical characteristics of patients.
PatientSexAge
(years)
Epilepsy typePMD/IQNeurological examinationBrain MRIEEGSeizure typeAED therapy
1M16Epileptic encephalopathySevereDouble hemiparesisAtrophy; polymicrogyriaMultiple fociFixed gaze and upper limb hypertonusTPM–CBZ–RUF–CZP-(KD)
2M12Epileptic encephalopathyProfoundSpastic tetraparesisPeriventricular leukomalaciaMultiple fociRight side hypertonus with head deviationPB–CBZ-(KD)
3M16Epileptic encephalopathyProfoundSpastic tetraparesisBrain migration disorderGeneralized SWTonic seizures (10 s)VPA–PB–LEV–clobazam
4F9Epileptic encephalopathy; LYS1 deletionProfoundspastic/hypotonic cerebral palsyLissencephalyMultiple foci and generalized SWCluster of eating-induced spasmsVPA
5M5Epileptic encephalopathy; CMV infection; microcephalyProfoundSpastic tetraparesisBrain atrophy; multiple calcificationsDiffuse and focal S and polyspike WCluster of asymmetric spasmsRUF–PB–VPA–GVG
6M8Epileptic encephalopathyProfoundSpastic/distonic tetraparesisBrain atrophy; polymicrogyriaMultiple fociTonic spasmsCBZ–PB–GVG–LEV–BDZ–baclofen
7M21Epileptic encephalopathySevereSpastic tetraparesisBrain atrophyMultiple fociGeneralized clonic seizuresPB–OXC–CZP–LCM
8F11Epileptic encephalopathySevereSpastic tetraparesisBrain atrophyRight frontal–occipital SWHead and eye version with limb tremorCBZ–clobazam–PB
9F1.5Epileptic encephalopathySevereRight hemiparesisHemimegalencephalySW discharges over right hemisphereCluster of spasmsVPA–GVG–PB
10F15Epileptic encephalopathy, chrom. 14, monosomy, chrom. 9 trisomyProfoundSpastic tetraparesisBilateral polymicrogyriaMultiple fociGeneralized hypertonusPB–TPM–clobazam
11M17Epileptic encephalopathySevereSpastic tetraparesisBrain atrophyPolyspike and wave dischargesFixed gaze and unresponsivenessVPA–TPM–LTG–NZP
CBZ, carbamazepine; PB, phenobarbital; LEV, levetiracetam; VPA, valproic acid; LTG, lamotrigine; OXC, oxcarbazepine; VIG, vigabatrin; TMP, topiramate; RUF, rufinamide; KD, ketogenic diet; BDZ, benzodiazepine; NZP, nitrazepam; PMD, psychomotor development; IQ, intelligence quotient; AED, antiepileptic drug; MRI, magnetic resonance imaging; EEG, electroencephalogram; SW, spike and wave.
The mean number of the antiepileptic drugs was 3.4; two patients were also on a ketogenic diet.
Seizure recurrence relative to all patients before, during, and after music therapy is shown in Fig. 1. During the 15-day music therapy, 2 out of 11 patients had a reduction of 50–75% in seizure recurrence, and 3 out of 12 patients had a reduction of 75–89%. None of the patients were seizure-free. The remaining patients showed minimal or no changes in seizure frequency (a decrease of 25–49% in 2, less than 25% in 2, and unchanged in the other 2). Overall, 5 (45.4%) out of 11 patients had a ≥ 50% reduction in the total number of seizures, while the percentage decrease of the total seizure number (11/11) compared with baseline was − 51.5% during the 15-day music therapy and − 20.7% in the two weeks after the end of treatment. The average percentage seizure reduction for all patients at the end of music treatment compared with the premusic seizure frequency was 48.4 ± 48.7% (CI = 56 ± T(10) ∗ 21.18662, p = 0.02; Student's t-test). No statistically significant difference was observed between patients with different severities in IQ (p = .111), etiology (p = .109), gender (p = .107), and seizure type (p = .107).
Total number of daily seizures among the enrolled patients (N=11) prior to music ...
Fig. 1. 
Total number of daily seizures among the enrolled patients (N = 11) prior to music exposure and during and after music therapy. *, p = 0.02 (Student's t-test).
With respect to the relationship between the response to music therapy and the localization of spike-and-wave discharges, occipital/bioccipital discharges were present in 20% of the responders and in 66.7% of the nonresponders (Fig. 2).
Comparison of occipital foci between responders and nonresponders.
Fig. 2. 
Comparison of occipital foci between responders and nonresponders.
Nighttime sleep was improved (easier falling asleep and less early morning awakenings) in 4 (36.4%) out of 11 patients; all were included among responders. One of the responders, however, had a regular sleep before treatment.
According to their relatives, all responders also presented a behavioral improvement, i.e., being more quiet and attentive to the environmental stimuli. Treatment compliance was generally good both in children and in parents.

4. Discussion

In this short-term prospective study, music therapy, consisting of a set of Mozart's compositions administered according to the principles of the Tomatis method, was associated with a significant reduction in seizure recurrence and an improved daytime behavior and quality of nighttime sleep in about 45% of children and adolescents with drug-resistant epileptic encephalopathies associated with psychomotor developmental delay/intellectual disability.
Currently, there are a few reports on the effect of music listening on interictal epileptic discharges [1], [2] and [3] and seizure recurrence [4], [5], [6], [7] and [8].
Lin et al. [2] report a reduction of interictal discharges from different foci following administration of Mozart's K448 sonata for 2 pianos in D major in children with epilepsy. The reduction was more evident for generalized and parietal spike-and-wave discharges, employing a piece of music with more fundamental tones and lower harmonic frequencies. These authors concluded, therefore, that it is possible to reduce the interictal epileptogenic discharges in some patients by optimizing the fundamental tones and by minimizing higher harmonic frequencies.
The long-term efficacy (> 6 months) of Mozart's K448 on interictal epileptogenic discharges was later confirmed by Lin et al. [3] in 18 children suffering mainly from idiopathic epilepsies. These authors also reported a best response in nonoccipital foci.
With respect to the effect of music listening on seizure recurrence, there is currently only one randomized controlled study [8] and a few open trials.
Lin et al. [7] evaluated the efficacy of music therapy in 11 children, between 2.9 years and 14.4 years of age, with refractory cryptosymptomatic epilepsy, and treated for 6 months with music stimulation consisting of Mozart k448 every night for the duration of 8 min.
During the 6-month treatment, a > 50% seizure reduction was achieved in 72.7% of the patients, including 2 who were seizure-free. No correlation was observed with IQ, etiology, and sex. The best response was reported in generalized seizures. In the only randomized controlled trial, conducted by Bodner et al. [8], music therapy (Mozart K448) was administered to an institutionalized adult population with refractory epilepsy and mental retardation followed-up for 3 years. The music stimulation was administered for the full night sleep, at regular intervals of 8.5 min each per hour for one year, leading to a 24% reduction of the total seizure recurrence compared with baseline period and a “carryover” effect after discontinuation of − 33% of the total seizure number.
Interestingly, a significant effect on seizure recurrence was reported in a few adults with focal-onset drop attacks [4] and [5] and in two patients with nonconvulsive status epilepticus [6] and [9].
More recently, Lin et al. [12] investigated the effect of listening to Mozart K.448 in reducing the seizure recurrence rate in children with first unprovoked seizures, most of them with idiopathic, benign forms of focal or generalized epilepsy and normal intellectual functioning. After a six-month follow-up, listening to Mozart K.448 significantly decreased the seizure recurrence rate and the amount of spike-and-wave discharges.
In our series, the particularly severe epileptic encephalopathies in all patients in a context of delayed psychomotor development/intellectual disability and cerebral palsy could, to some extent, explain why music therapy was less effective and associated with a smaller carryover effect compared with Lin et al. [2].
In our sample, although interictal spike-and-wave discharges were overall unchanged (possibly due to the clinical severity in all patients), there was, nonetheless, a significantly lower incidence of occipital foci in responders (20% vs. 66.7% in nonresponders) in agreement with Lin et al. [3]. Indeed, central, frontal, temporal, and parietal discharges as well as bursts of generalized spikes and polyspike-and-wave discharges were present mainly in the responder group.
In this regard, Lin et al. [3] suggest that occipital foci could be excluded from the temporal–parietal–frontal auditory network. These data, of course, need to be further studied.
Of interest is the apparent beneficial effect of music therapy on nocturnal sleep as reported in some of our children. Parents, in fact, reported a decrease in time to fall asleep, with fewer nighttime awakenings and less early morning awakenings. Similarly, some children showed a behavioral improvement consisting of reduced self-/hetero-aggression, less irritability, and mood instability with less frequent crying spells. Whether there is a correlation between improved sleep and reduction in seizures will require further study.
Improved attention and participation to the environmental stimuli in some children, not reported so far, to our knowledge, might be correlated with the beneficial effect of music therapy on mood [13] as well as on cognition [14] and with the well-known effect of activation of parasympathetic tone [15].
As to the kind of music, in the present study, a set of Mozart's compositions with musical instruments other than pianos and rhythmic characteristics somewhat close to K448 were used in order to assess a potential alternative to K448. Music strings with high harmonics (> 3000 Hz) were also selected according to the principles of the Tomatis method based on the electronic ear [10].
According to Tomatis, indeed, high-frequency sounds are an important form of stimulation for the brain. It is, in fact, well known that 80% of the 34,000 hair cells in the cochlea respond to sound above 3000 Hz. Accordingly, a modified device based on the Tomatis principles provided high-frequency filtered music by means of electronic gating.
The transosseous sound transmission offered by the headset allows us to directly convey the sound to the inner ear. As for the optimum length of the music stimulation, it is so far not well established. In the present study, we decided to extend it to 2 h each day (whether in wakefulness or sleep), also in view of the clinical severity in our patients, who appeared generally compliant with this treatment.
Furthermore, the use of headphones was considered, firstly, to avoid noisy environmental interference with the music listening and, secondly, to avoid potential poor compliance in the family group. A wider set of musical compositions was also selected to improve children's compliance with music listening.

4.1. Limitations and strengths of the study

The limitations of this study are mainly the study design (nonrandomized, prospective, open-label), the small sample size, and the short-term duration. The homogeneity of the sample (all children with severe, refractory epileptic encephalopathies and intellectual disability/cerebral palsy), the use of music other than Mozart's sonata for two pianos in D major, K448, the use of music strings with high harmonics (> 3000 Hz) according to the principles of the Tomatis method, based on the electronic ear, close monitoring of each patient throughout the study with respect to behavioral changes and sleep quality, together with a longer duration of daily music listening, and an unchanged drug therapy during each single study phase may represent potential strengths.
In conclusion, this study appears to confirm what has been reported so far on the effectiveness of music therapy on seizure recurrence and behavioral improvement in some children with refractory epilepsy, although there is still a need for further controlled studies both on clinical effectiveness regarding, in particular, seizure type, localization of epileptiform discharges, and patients's age, and on the kind and duration of music stimulation.
We, of course, agree with Maguire [16] that there is limited evidence for an anticonvulsant effect of music listening in epilepsy so far and that its therapeutic potential remains for the moment largely unproven, with our understanding of the involved brain mechanisms being very limited.
However, the clinical improvement in some children and the significant parents' satisfaction at the end of this preliminary study encourage us to continue the objective assessment of this promising, complementary treatment of epilepsy.

Conflict of interest

All authors declare the absence of any potential conflicts of interest.

References

    • [8]
    • M. Bodner, R.P. Turner, J. Schwacke, C. Bowers, C. Norment
    • Reduction of seizure occurrence from exposure to auditory stimulation in individuals with neurological handicaps: a randomized controlled trial
    • PLoS One, 7 (2012), p. e45303
    • [11]
    • Commission on Classification and Terminology of the International League Against Epilepsy
    • Proposal for revised clinical and electroencephalographic classification of epileptic seizures
    • Epilepsia, 22 (1981), pp. 489–501

    • [12]
    • L.C. Lin, M.W. Lee, R.C. Wei, H.K. Mok, R.C. Yang
    • Mozart K.448 listening decreased seizure recurrence and epileptiform discharges in children with first unprovoked seizures: a randomized controlled study
    • BMC Complement Altern Med, 13 (2014), pp. 14–17
    •  | 
    • [13]
    • A. Raglio, L. Attardo, G. Gontero, S. Rollino, E. Groppo, E. Granieri
    • Effects of music and music therapy on mood in neurological patients
    • World J Psychiatry, 5 (2015), pp. 68–78
    •  | 

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου